Most men arrive at this question after the first search rather than before it. The diagnosis is settled. What isn't settled is which kind you have, and that turns out to be the part that changes everything downstream.
The causes of erectile dysfunction sort into four mechanisms rather than into the list of fifteen risk factors most pages offer. Erectile dysfunction is the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance, and an erection is a sequence: a nerve signal, a chemical messenger, blood arriving under pressure, blood held in place, and tissue elastic enough to expand. Four things can break in that sequence. Vascular, neurogenic, hormonal, structural.
A risk factor tells you what you have. The erection mechanism tells you which step broke, and that's the question a clinician is working toward when they ask when it started and whether it happens every time. This article takes each category in turn: the mechanism behind it, the conditions that produce it, and the pattern it usually leaves behind.
What Are the Four Causes of Erectile Dysfunction?
Organic erectile dysfunction falls into four mechanistic categories: vascular, neurogenic, hormonal, and structural. Each one corresponds to a different point of failure in the erection sequence. Vascular ED is a blood flow problem, neurogenic ED a signaling problem, hormonal ED an upstream chemistry problem, and structural ED a tissue problem.
- Vascular: blood cannot get in fast enough, or cannot be held once it arrives.
- Neurogenic: the arousal signal is damaged before it reaches the erectile tissue.
- Hormonal: low testosterone weakens desire and the chemical signaling an erection depends on.
- Structural: the erectile tissue itself can no longer expand enough to trap blood.
The four types of erectile dysfunction differ in where the sequence fails, not only in what caused the damage. In the table below, vascular ED is set out as its two subtypes, arterial and venous, because they fail at opposite ends of the same step: the categories still number four.
| CATEGORY | WHERE THE SEQUENCE FAILS | COMMON UNDERLYING CONDITIONS | MEDIAN IIEF-5 |
| Vascular · arterial subtype | Arterial inflow is restricted before it reaches the erectile chambers | Atherosclerosis, hypertension, diabetes, metabolic syndrome, smoking | 13, mild to moderate |
| Vascular · venous subtype | Blood arrives, but the veno-occlusive mechanism fails to trap it | Venous leak, corporal smooth muscle loss, long-standing arterial disease | 13, mild to moderate |
| Neurogenic | The signal never reaches the tissue, or arrives too weakly to matter | Spinal cord injury, MS, Parkinson's, stroke, diabetic neuropathy, pelvic surgery | 12, mild to moderate |
| Hormonal | Desire and nitric oxide signaling are blunted upstream of both | Hypogonadism, androgen deprivation therapy, pituitary disorders, medications | 12-13, mild to moderate |
| Structural | The erectile chambers cannot expand far enough to seal the veins | Peyronie's disease, corporal fibrosis, penile trauma, congenital change | 12, mild to moderate |
Other pages count five causes. Some count seven. The number keeps moving because those pages are listing risk factors rather than mechanisms, and a risk factor list has no natural stopping point: diabetes, smoking, hypertension, depression, sleep apnea and a dozen prescription drug classes all belong on it, and not one of them is a point of failure. They're things that damage a point of failure. Several damage more than one.
A taxonomy built on mechanisms stops at four, because the erection sequence has four places where it can fail: the vessels that deliver and trap blood, the nerves that carry the signal, the hormones that sustain desire and tissue responsiveness, and the tissue that has to expand. Psychogenic ED looks like the obvious fifth. It's not a category at all.
What Is Vascular ED?
Vascular ED is a failure of blood flow into or out of the erectile chambers. Arterial disease restricts how much blood can arrive, or the seal that should trap blood inside fails, and it drains as quickly as it fills. Clinically, that seal is the veno-occlusive mechanism. Vascular causes are the most common category in men over 50.
The arterial version starts in the endothelium, the single-cell lining of the blood vessels that releases nitric oxide on demand: endothelial dysfunction blunts that release, atherosclerosis narrows the vessel itself, and between them the artery loses its ability to dilate on cue. The venous version is different in kind. Blood arrives normally, but the expanding chambers no longer press the small draining veins against the surrounding sheath hard enough to seal them, so pressure never builds. Clinicians call that a venous leak or veno-occlusive failure.
The pattern is gradual. Function declines over months or years rather than overnight; it stays consistent regardless of partner or setting, and it tracks whatever else is happening cardiovascularly. If your blood pressure, cholesterol, or blood sugar have been drifting for years, the same process is very likely at work in both places.
That overlap has a physical reason. The penile arteries are substantially narrower than the coronary arteries, so an identical burden of plaque produces a noticeable effect in the penis long before it produces chest pain. That's why ED is treated as an early cardiovascular signal: symptoms typically appear 2 to 3 years before angina and around 3 to 5 years before a major cardiovascular event. So a new and gradual erection problem is a reason to have your cardiovascular risk assessed properly, especially if it’s something you might otherwise consider to be simply age-related.
What Is Neurogenic ED?
Neurogenic ED is a signaling failure. The blood vessels and the erectile tissue can be entirely healthy, but the instruction to begin an erection never arrives, or arrives too weakly to produce one.
The damage sits either centrally or peripherally. Central causes interrupt the signal in the brain or the spinal cord: spinal cord injury, multiple sclerosis, Parkinson's disease and stroke are the common ones. Peripheral causes damage the nerves on the route to the penis, most often through diabetic autonomic neuropathy or injury to the cavernosal nerves during pelvic surgery or radiation, and prostatectomy is the familiar example because those nerves run directly alongside the prostate.
This one is easier to date. Onset traces to a specific event or diagnosis rather than emerging quietly over years, and nocturnal erections tend to disappear alongside the daytime ones. If you can name the month it changed, start here.
The mechanism matters for treatment in a way the other three don't. A PDE5 inhibitor does not create an erection. It amplifies the signal the body is already sending. Where the signal is itself the damaged part, the drug has less to work with, which is why response rates in men with significant nerve injury sit below what the same drug achieves in the general ED population. In broad terms, PDE5 inhibitors help roughly 60–80% of men with non-neurogenic ED, but only about 30–60% of men with substantial neurogenic injury (for example, after non–nerve-sparing prostatectomy). But that doesn't mean nothing works; it instead means that the treatment options that don’t need nerves move up the list.
What Is Hormonal ED?
Hormonal ED begins upstream of both the plumbing and the wiring. Testosterone deficiency reduces sexual desire and blunts the nitric oxide signaling inside penile tissue itself, so the erection is weakened at its chemical origin rather than at the point of delivery.
The distinguishing feature is that desire falls too. In vascular and neurogenic ED, a man generally still wants sex and can't complete it, which is its own particular frustration; in hormonal ED, the interest itself thins out, usually alongside fatigue, low mood, loss of muscle mass, and poorer sleep. If your libido dropped at the same time your erections did, you should say so at the appointment, because that combination is what sends a clinician toward a morning testosterone test rather than a vascular workup.
The common causes are hypogonadism, meaning the testicles produce too little testosterone either because of a problem in the testicles themselves or because of the signal reaching them, along with pituitary disorders and androgen deprivation therapy, the hormone treatment used for prostate cancer. ADT is the most severe of them by design. It suppresses testosterone to castrate level, typically under 50 ng/dL, meaning a level as low as it would be if the testicles had been removed, and sexual function falls through desire and tissue responsiveness together rather than through either one alone.
Medication-induced ED belongs in this category as well. The drug classes most commonly associated with ED include antihypertensives, antidepressants, antiandrogens, and others that act through hormonal and vascular pathways rather than constituting a fifth mechanism. Timing is the clue with this type of ED. Erectile change that starts within weeks of a new prescription is worth raising with the prescriber rather than just accepting as normal.
What Is Structural ED?
Structural ED is a tissue problem. The nerves fire, the hormones are adequate and the blood arrives, but the erectile chambers can no longer expand far enough to seal the veins and hold it. The failure is mechanical, not chemical.
Peyronie's disease is the most recognizable form. Fibrous plaque forms within the tunica albuginea, the sheath around each erectile chamber, producing curvature, pain on erection and a firm area a man can often feel. Corporal fibrosis is the quieter version. Sustained ‘cavernosal hypoxia’ drives the replacement of smooth muscle with collagen, a process called corporal fibrosis, and collagen can't relax in response to nitric oxide as smooth muscle does. Penile trauma, prior priapism, and congenital abnormality account for most of the remainder.
Structural ED is the least common of the four categories. It’s also among the most severe: In a multicenter cohort of over 3,000 men with ED, anatomical/structural causes accounted for only 2.8% of cases, compared with 21% vasculogenic, 4% neurogenic, and 7% hormonal. Men with organic causes including structural disease had a median IIEF‑5 of 12 (mild to moderate ED), versus 15 (also mild to moderate) in psychogenic ED, and all organic subgroups clustered in the moderate range.
There's a second reason this type of ED is less separate than it looks: structural change is frequently the downstream consequence of erectile dysfunction that began somewhere else. Erections oxygenate the tissue, so when they stop happening for long enough, the tissue fibroses, and fibrosis is partly self-reinforcing once it takes hold. Untreated vascular or neurogenic ED can become structural ED given time, which is the strongest argument yet for not waiting to be assessed.
Where Does Psychogenic ED Fit?
Psychogenic ED is a modifier that acts across all four categories rather than a fifth category sitting beside them. The reason is a mechanical one. Anxiety and stress activate the sympathetic nervous system, which contracts the same cavernosal smooth muscle that nitric oxide is trying to relax, so one branch of the nervous system works directly against the other.
Nothing in the sequence is damaged. An intact system is being overridden, which is why the practical marker is preserved nocturnal function rather than anything visible on a scan. Healthy men typically produce about 3 to 5 erections per night during REM sleep, each lasting roughly 15 to 40 minutes. And if you still wake with erections, the hardware is working, and the problem sits upstream of it.
In a recent clinical cohort, roughly 85 to 90% of men presenting with ED had a primarily organic cause and about 10 to 15% a primarily psychogenic cause. That figure comes from a clinical cohort rather than a population sample, so it describes men who presented for treatment rather than all men with symptoms.
The two coexist constantly, which is the part a split figure obscures. A man with early vascular ED who begins anticipating failure acquires a psychogenic component on top of the original one, and from that point each mechanism reinforces the other.
Can You Have More Than One Cause at the Same Time?
Yes, and with age it becomes the norm rather than the exception. Mixed-etiology ED means two or more mechanisms failing at once, most often a vascular process alongside a hormonal, psychogenic one, or lifestyle-led one.
The numbers suggest that combinations are worse than their parts: mixed vascular ED, in which arterial inflow and venous trapping are both impaired, carries the lowest median IIEF-5 of the vascular subtypes. In the same multicenter cohort of over 3,000 men mentioned earlier, mixed vascular ED had a median IIEF-5 of 11, compared with 13 for pure arterial or pure venous disease. More than one failure point compounds rather than averages out.
So a man who can't place himself cleanly in one of the four boxes almost certainly hasn't misread the framework. He has probably read it correctly, and the honest answer is that the boxes describe mechanisms rather than patients. Most men past a certain age carry more than one, and a workup that stops at the first plausible explanation tends to miss the second. If you can see yourself in two or more categories, it’s important that you take all the information about them to the appointment.
Frequently Asked Questions
-
What are the major causes of erectile dysfunction?
Erectile dysfunction has four organic causes: vascular, neurogenic, hormonal, and structural. Vascular ED restricts blood flow into or out of the penis. Neurogenic ED interrupts the nerve signal that starts an erection. Hormonal ED lowers testosterone and the desire and tissue responsiveness that depend on it. Structural ED limits how far erectile tissue can physically expand.
-
What are organic causes of erectile dysfunction?
Organic ED covers physical failures somewhere in the erection sequence, as distinct from psychological ones. They include vascular disease affecting inflow or venous trapping, nerve damage from injury, surgery or neuropathy, hormone deficiency such as low testosterone, and structural change to the erectile tissue. Organic and psychological causes frequently occur together in the same man.
-
How do I know which type of erectile dysfunction I have?
Three features narrow it considerably before any test is ordered. Onset: gradual points toward vascular, while sudden or event-linked points toward neurogenic or psychogenic. Consistency: constant points toward an organic cause, situational toward a psychogenic one. Nocturnal erections: if yours persist, the physical machinery is intact. A clinician confirms with examination and bloodwork.
-
Can erectile dysfunction have more than one cause?
Yes, and it commonly does. Mixed-etiology erectile dysfunction, in which two or more mechanisms fail together, becomes more likely with age and with accumulated medical history. A vascular process combined with low testosterone, or with performance anxiety, is a frequent pattern. Multiple mechanisms tend to produce more severe dysfunction than any single one alone.
-
Is psychological erectile dysfunction different from physical erectile dysfunction?
Both are genuine physiological events, but they differ in origin. Psychological erectile dysfunction overrides an intact system through sympathetic nervous system activity that opposes the relaxation an erection requires. Physical erectile dysfunction damages part of the system itself. Erections that continue during sleep point toward a psychological origin rather than a physical one.
So Which One Is Yours?
It’s a good idea to start with recognizing the pattern, not the label. Gradual, consistent decline alongside rising cardiovascular risk points toward vascular ED. A change you can date to a surgery, an injury or a neurological diagnosis points toward neurogenic. Desire that fell away alongside function points toward hormonal. Curvature, pain, or a firm palpable area points toward structural.
Knowing which one is yours isn't an academic exercise: it determines which tests get ordered first, which specialty you're referred to, and whether a PDE5 inhibitor has a signal available to amplify at all.
Take three things to the appointment. When it started, whether it happens every time, and whether erections still occur during sleep. Those three answers start to narrow the diagnosis further than any single test does.
References:
Johns Hopkins Medicine. "Erectile Dysfunction." Johns Hopkins Medicine, [n.d.]. https://www.hopkinsmedicine.org/health/conditions-and-diseases/erectile-dysfunction
European Association of Urology. "EAU Guidelines on Sexual and Reproductive Health." Uroweb (European Association of Urology), [n.d.]. https://uroweb.org/guidelines/sexual-and-reproductive-health Accessed YYYY-MM-DD.
Lowe G, Bahnson R. "Non-invasive management of primary phosphodiesterase type 5 inhibitor failure in patients with erectile dysfunction." Therapeutic Advances in Urology, 2009. https://pmc.ncbi.nlm.nih.gov/articles/PMC3126073/
El-Sakka AI. "Reversion of penile fibrosis: Current information and a new horizon." Arab Journal of Urology, 2011. https://pmc.ncbi.nlm.nih.gov/articles/PMC4149188/
Tang Z, Li D, Zhang X, et al. "Comparison of the simplified International Index of Erectile Function (IIEF-5) in patients of erectile dysfunction with different pathophysiologies." BMC Urology, 2014. https://link.springer.com/article/10.1186/1471-2490-14-52
Ferrini MG, Kovanecz I, Sanchez S, Umeh C, Rajfer J, Gonzalez-Cadavid NF. "Fibrosis and loss of smooth muscle in the corpora cavernosa precede corporal veno-occlusive dysfunction (CVOD) induced by experimental cavernosal nerve damage in the rat." The Journal of Sexual Medicine, 2009. https://pmc.ncbi.nlm.nih.gov/articles/PMC2756287/
Andersen ML, Tufik S. "The role of sleep stages in the regulation of erectile function: impacts of REM sleep fragmentation." International Journal of Impotence Research, 2026. https://www.nature.com/articles/s41443-026-01240-9
Pozzi E, Fallara G, Capogrosso P, et al. "Primary organic versus primary psychogenic erectile dysfunction: Findings from a real-life cross-sectional study." Andrology, 2022. https://onlinelibrary.wiley.com/doi/10.1111/andr.13212
Raveendran AV. "Erectile dysfunction: Proposed definition and staging for early diagnosis." World Journal of Methodology, 2026. https://pmc.ncbi.nlm.nih.gov/articles/PMC12968756/
Montorsi P, Montorsi F. "Erectile dysfunction as a predictor of coronary artery disease." International Journal of Impotence Research, 2005. https://pubmed.ncbi.nlm.nih.gov/15950839/
Imprialos K, Koutsampasopoulos K, Manolis A, Doumas M. "Erectile dysfunction as a cardiovascular risk factor: Time to step up?" Current Vascular Pharmacology, 2021. https://pubmed.ncbi.nlm.nih.gov/32286949/
Thomas C, Konstantinidis C. "Neurogenic erectile dysfunction. Where do we stand?" Medicines (Basel), 2021. https://pmc.ncbi.nlm.nih.gov/articles/PMC7825654/
Walsh PC, Donker PJ. "Impotence following radical prostatectomy: Insight into etiology and prevention." Journal of Urology, 1982. https://pubmed.ncbi.nlm.nih.gov/7120537/
Montorsi P, et al. "Erectile dysfunction after radical prostatectomy: Hemodynamic profiles and response to sildenafil." Journal of Urology, 2000. https://pubmed.ncbi.nlm.nih.gov/11063900/
Corona G, et al. "Testosterone and erectile function: A systematic review and meta-analysis." Journal of Sexual Medicine, 2013. https://pubmed.ncbi.nlm.nih.gov/23627687/
Saenz de Tejada I. "Physiology of erectile function." Journal of Sexual Medicine, 2004. https://pubmed.ncbi.nlm.nih.gov/15469466/


